AccuLase gets $1 million Baxter TMR (transmyocardial revascularisation) order:
This article was originally published in Clinica
Executive Summary
Laser Photonics subsidiary AccuLase has received a $1 million order for additional lasers from Baxter Healthcare, in connection with both companies' collaborative transmyocardial revascularisation (TMR) programme. The San Diego, California-based AccuLase expects to begin shipping in the third quarter.
You may also be interested in...
Common Regulatory Starting Point Means EU-UK Are On Track For Medtech MRA, Say German Firms
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
COVID-19 Vaccines Donated To Philippines Require Emergency Use Authorization
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: